|
1
|
Kleihues P, Louis DN, Scheithauer BW,
Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO
classification of tumors of the nervous system. J Neuropathol Exp
Neurol. 61:215–225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, van den Bent MJ and Hegi ME:
Optimal role of temozolomide in the treatment of malignant gliomas.
Curr Neurol Neurosci Rep. 5:198–206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anderson HJ and Galileo DS: Small-molecule
inhibitors of FGFR, integrins and FAK selectively decrease
L1CAM-stimulated glioblastoma cell motility and proliferation. Cell
Oncol (Dordr). 39:229–242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El Hallani S, Boisselier B, Peglion F,
Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL,
Eichmann A, et al: A new alternative mechanism in glioblastoma
vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Folberg R, Hendrix MJ and Maniotis AJ:
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol.
156:361–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guzman G, Cotler SJ, Lin AY, Maniotis AJ
and Folberg R: A pilot study of vasculogenic mimicry
immunohistochemical expression in hepatocellular carcinoma. Arch
Pathol Lab Med. 131:1776–1781. 2007.PubMed/NCBI
|
|
7
|
King LS, Yasui M and Agre P: Aquaporins in
health and disease. Mol Med Today. 6:60–65. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohammadi MT and Dehghani GA: Nitric oxide
as a regulatory factor for aquaporin-1 and 4 gene expression
following brain ischemia/reperfusion injury in rat. Pathol Res
Pract. 211:43–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yao X, Derugin N, Manley GT and Verkman
AS: Reduced brain edema and infarct volume in aquaporin-4 deficient
mice after transient focal cerebral ischemia. Neurosci Lett.
584:368–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oshio K, Binder DK, Liang Y, Bollen A,
Feuerstein B, Berger MS and Manley GT: Expression of the
aquaporin-1 water channel in human glial tumors. Neurosurgery.
56:375–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rouzaire-Dubois B, Ouanounou G and Dubois
JM: Relationship between extracellular osmolarity, NaCl
concentration and cell volume in rat glioma cells. Gen Physiol
Biophys. 30:162–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie Y, Wen X, Jiang Z, Fu HQ, Han H and
Dai L: Aquaporin 1 and aquaporin 4 are involved in invasion of lung
cancer cells. Clin Lab. 58:75–80. 2012.PubMed/NCBI
|
|
15
|
Klein G, Vellenga E, Fraaije MW, Kamps WA
and de Bont ES: The possible role of matrix metalloproteinase
(MMP)-2 and MMP-9 in cancer, eg acute leukemia. Crit Rev Oncol
Hematol. 50:87–100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roy R, Yang J and Moses MA: Matrix
metalloproteinases as novel biomarkers and potential therapeutic
targets in human cancer. J Clin Oncol. 27:5287–5297. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiao Y, Feng X, Zhan Y, Wang R, Zheng S,
Liu W and Zeng X: Matrix metalloproteinase-2 promotes αvβ3
integrin-mediated adhesion and migration of human melanoma cells by
cleaving fibronectin. PLoS One. 7:e415912012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brooks PC, Clark RA and Cheresh DA:
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
Science. 264:569–571. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuphal S, Bauer R and Bosserhoff AK:
Integrin signaling in malignant melanoma. Cancer Metastasis Rev.
24:195–222. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
21
|
Wu Z, Li S, Liu J, Shi Y, Wang J, Chen D,
Luo L, Qian Y, Huang X and Wang H: RNAi-mediated silencing of AQP1
expression inhibited the proliferation, invasion and tumorigenesis
of osteosarcoma cells. Cancer Biol Ther. 16:1332–1340. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pelagalli A, Nardelli A, Fontanella R and
Zannetti A: Inhibition of AQP1 hampers osteosarcoma and
hepatocellular carcinoma progression mediated by bone
marrow-derived mesenchymal stem cells. Int J Mol Sci. 17:E11022016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K,
Pang JC, Ng HK and Chen ZP: Clinical significance of vasculogenic
mimicry in human gliomas. J Neurooncol. 105:173–179. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kirschmann DA, Seftor EA, Hardy KM, Seftor
RE and Hendrix MJ: Molecular pathways: Vasculogenic mimicry in
tumor cells: Diagnostic and therapeutic implications. Clin Cancer
Res. 18:2726–2732. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nicchia GP, Stigliano C, Sparaneo A, Rossi
A, Frigeri A and Svelto M: Inhibition of aquaporin-1 dependent
angiogenesis impairs tumour growth in a mouse model of melanoma. J
Mol Med(Berl). 91:613–623. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Saadoun S, Papadopoulos MC, Hara-Chikuma M
and Verkman AS: Impairment of angiogenesis and cell migration by
targeted aquaporin-1 gene disruption. Nature. 434:786–792. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yue WY and Chen ZP: Does vasculogenic
mimicry exist in astrocytoma? J Histochem Cytochem. 53:997–1002.
2005. View Article : Google Scholar : PubMed/NCBI
|
